Pfizer’s TUKYSA Regimen Wins FDA Approval for Front-Line Maintenance in HER2+ Metastatic Breast Cancer
FDA Approves Pfizer’s TUKYSA Regimen for First-Line Maintenance in HER2+ Metastatic Breast Cancer Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved TUKYSA® (tucatinib) in combination…
Pearl Diagnostics Publishes Clinical Studies Supporting FDA Clearance of MycoMEIA® Aspergillus Assay
PearlDX Publishes Clinical Evidence Supporting FDA-Cleared MycoMEIA Urine Test for Invasive Aspergillosis Pearl Diagnostics, also known as PearlDX, has announced the publication of new clinical studies supporting the U.S. Food…
Medisca and EUROAPI Partner to Expand API Access for Pharmaceutical Compounding
Medisca and EUROAPI Form Strategic Partnership to Expand API Access for Pharmaceutical Compounding Medisca and EUROAPI have entered into a strategic partnership designed to expand access to active pharmaceutical ingredients…
Bridge Neurotech, Butterfly Network Partner on Non-Invasive Brain-Computer Interface
Bridge Neurotech Emerges from Stealth with Non-Invasive Brain-Computer Interface Vision, Partners with Butterfly Network Bridge Neurotech, a company developing a completely non-invasive brain-computer interface (BCI), has emerged from stealth with…
RoslinCT Secures £7.25M Grant for Digital Cell Therapy Manufacturing
RoslinCT Secures Up to £7.25 Million Scottish Enterprise Grant to Accelerate Digital Transformation of Cell Therapy Manufacturing RoslinCT, a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell…
Invivoscribe Expands Molecular Clonality Testing Portfolio with LymphoTrack Flex Suite
Invivoscribe Launches Complete LymphoTrack Flex Suite for NGS-Based Clonality and MRD Analysis Invivoscribe, a global provider of precision diagnostics and measurable residual disease (MRD) testing solutions, has announced the launch…
Dexcom U Enters Season 5 as Diabetes Stigma Fades
Dexcom Launches Fifth Season of Dexcom U NIL Program for College Athletes With Diabetes Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, has launched the fifth season of…
City of Hope Appoints New Presidents for Cancer Centers in Arizona and Atlanta
City of Hope Names Laurie Sicaeros and Melissa Childress to Lead Cancer Centers in Arizona and Atlanta City of Hope, one of the largest and most advanced cancer research and…
Nitto Avecia Receives Third Consecutive FDA Inspection with No Action Indicated
Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S.…
Shape Memory Medical Receives ANVISA Approval for IMPEDE Embolization Plug Family in Brazil
Shape Memory Medical Receives ANVISA Authorization for IMPEDE Embolization Plug Portfolio in Brazil Shape Memory Medical Inc., a medical technology company developing volume-expanding shape memory polymer solutions for endovascular embolization,…
NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board
NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board as Company Advances Neurotechnology Platform Appoints®, a neurotechnology company focused on developing non-invasive solutions to help restore function and independence for…
Exthymic Secures Up to $25M ARPA-H Contract for Hospital-Based Cell Therapy Production
Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies,…